Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 29, 2025	ARS	An annual report to security holders	0001517022-25-000025.pdf 0001517022-25-000025.rtf View HTML
April 17, 2025	SCHEDULE 13G/A	SCHEDULE 13G/A - Description	0001576419-25-000548.pdf 0001576419-25-000548.rtf 0001576419-25-000548.xls View HTML
March 20, 2025	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001193125-25-059312.pdf 0001193125-25-059312.rtf 0001193125-25-059312.xls View HTML
March 20, 2025	8-K	Report of unscheduled material events or corporate event	0001193125-25-059327.pdf 0001193125-25-059327.rtf 0001193125-25-059327.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 19, 2025	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001193125-25-057843.pdf 0001193125-25-057843.rtf 0001193125-25-057843.xls View HTML
March 13, 2025	8-K	Report of unscheduled material events or corporate event	0001517022-25-000017.pdf 0001517022-25-000017.rtf 0001517022-25-000017.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 13, 2025	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001628280-25-012470.pdf 0001628280-25-012470.rtf 0001628280-25-012470.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 4, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-001997.pdf 0001562180-25-001997.rtf 0001562180-25-001997.xls View HTML
March 4, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-001998.pdf 0001562180-25-001998.rtf 0001562180-25-001998.xls View HTML
March 3, 2025	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-25-000011.pdf 0001517022-25-000011.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax